Management of Neuroblastoma: ICMR Consensus Document.

about

Editorial: Indian Guidelines for Treatment of Pediatric Malignancies.

P2860

Q53430445-3F200B62-5C92-4977-81ED-882B8621307B

P2860

Management of Neuroblastoma: ICMR Consensus Document.

Item

http://www.wikidata.org/entity/Q39214599

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Management of Neuroblastoma: ICMR Consensus Document.

@en

Management of Neuroblastoma: ICMR Consensus Document.

@nl

type

Item

label

Management of Neuroblastoma: ICMR Consensus Document.

@en

Management of Neuroblastoma: ICMR Consensus Document.

@nl

prefLabel

Management of Neuroblastoma: ICMR Consensus Document.

@en

Management of Neuroblastoma: ICMR Consensus Document.

@nl

P1476

Management of Neuroblastoma: ICMR Consensus Document

@en

P2093

Brijesh Arora

http://www.w3.org/2001/XMLSchema#string

G K Rath

http://www.w3.org/2001/XMLSchema#string

Gauri Kapoor

http://www.w3.org/2001/XMLSchema#string

Girish Chinnaswamy

http://www.w3.org/2001/XMLSchema#string

Maya Prasad

http://www.w3.org/2001/XMLSchema#string

Sameer Bakhshi

http://www.w3.org/2001/XMLSchema#string

Sandeep Agarwala

http://www.w3.org/2001/XMLSchema#string

Siddharth Laskar

http://www.w3.org/2001/XMLSchema#string

Sidharth Totadri

http://www.w3.org/2001/XMLSchema#string

Tanvir Kaur

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study.

Treatment and outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experience.

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.

Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy.

Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology Group.

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.

Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma.

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

P2888

s12098-017-2298-0

P304

446-455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12098-017-2298-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Deepak Bansal

Venkatraman Radhakrishnan

P577

2017-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28367616

http://www.w3.org/2001/XMLSchema#string

Management of Neuroblastoma: ICMR Consensus Document.

about

P2860

P2860

Management of Neuroblastoma: ICMR Consensus Document.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698